09/17/2025
3:45 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2025
3:24 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2025
10:10 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2025
3:26 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
08/29/2025
3:28 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
08/28/2025
7:00 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2025
9:03 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2025
5:22 PM | Khan Najat (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2025
5:22 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/19/2025
5:22 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2025
2:18 PM | Khan Najat (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for RXRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
08/13/2025
8:03 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/11/2025
2:31 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/05/2025
5:33 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2025
5:31 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2025
7:14 AM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
07/08/2025
7:19 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/03/2025
2:30 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2025
2:30 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
4:22 PM | Recursion Pharmaceuticals (Issuer)
Sun Elaine D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
4:22 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
4:23 PM | Bumpus Namandje (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
4:23 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
4:23 PM | HERSHBERG ROBERT (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
4:23 PM | Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2025
4:23 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:32 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:22 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
5:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2025
4:26 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
05/09/2025
4:27 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
5:07 AM | Recursion Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/05/2025
5:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/05/2025
5:02 AM | Recursion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/03/2025
3:37 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:37 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:38 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2025
3:52 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2025
11:02 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025
3:25 PM | Recursion Pharmaceuticals (Issuer)
Sun Elaine D (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/19/2025
3:26 PM | Bumpus Namandje (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
03/19/2025
3:27 PM | Recursion Pharmaceuticals (Issuer)
Sun Elaine D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:27 PM | Bumpus Namandje (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
3:27 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
7:01 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2025
3:16 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2025
10:55 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
9:13 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
6:26 AM | Recursion Pharmaceuticals (Filer)
| Form 424B5 | |
02/28/2025
5:31 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2025
5:33 AM | Recursion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/20/2025
3:42 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2025
3:42 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:41 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
10:23 AM | ARK Investment Management LLC (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025
4:07 PM | Recursion Pharmaceuticals (Filer)
| Form S-3ASR | |
02/12/2025
8:32 AM | BAILLIE GIFFORD & CO (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/06/2025
9:40 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2025
4:28 PM | BlackRock, Inc. (Filed by)
Recursion Pharmaceuticals (Subject)
| Form SCHEDULE 13G/A | |
02/05/2025
8:44 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2025
3:13 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/17/2025
4:09 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:12 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/14/2025
3:21 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
4:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
8:04 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
9:58 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2025
9:30 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/06/2025
5:02 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:02 PM | Li Dean Y (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:02 PM | Dar Zavain (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/26/2024
3:24 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2024
3:16 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
5:49 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/17/2024
4:05 PM | Recursion Pharmaceuticals (Filer)
| Form 424B7 | |
12/17/2024
4:06 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2024
3:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
4:46 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
9:29 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2024
9:32 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024
3:40 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2024
6:02 PM | Recursion Pharmaceuticals (Issuer)
Taylor Ben R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/27/2024
3:09 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/26/2024
3:48 PM | Recursion Pharmaceuticals (Filer)
| Form 8-K/A | |
11/22/2024
5:25 PM | Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/22/2024
5:25 PM | Michor Franziska (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
6:11 AM | Recursion Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/20/2024
6:14 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2024
5:26 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Marriott Tina (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
5:26 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
11/19/2024
5:26 PM | Mauro David J (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
5:52 PM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:19 PM | Recursion Pharmaceuticals (Issuer)
Secora Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2024
6:19 PM | Borgeson Blake (Reporting)
Recursion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
3:34 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
9:11 AM | Gibson Christopher (Reporting)
Recursion Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2024
8:22 AM | Recursion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2024
3:57 PM | Recursion Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/12/2024
1:48 PM | Recursion Pharmaceuticals (Subject)
Secora Michael (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
